A Study of the Efficacy and Safety of Brensocatib in Adults With Moderate to Severe Hidradenitis Suppurativa (HS)
This research study is looking at a new medicine called brensocatib for adults who have hidradenitis suppurativa (HS). HS is a long-term skin condition causing painful lumps and abscesses. We want to find out if brensocatib can help reduce these symptoms and if it's safe to use. Some participants will receive the new medicine, while others will receive a placebo (a dummy medicine with no active ingredients). This helps us compare the effects directly. The study is particularly for those with moderate to severe HS that has been present for at least six months. This type of research is an important step in finding new and better treatments for HS.
نظرة سريعة
ما هو موضوع هذه الدراسة؟
This study is about a new medicine called brensocatib and how it might help people with hidradenitis suppurativa, often called HS. HS is a long-term skin condition that causes painful, inflamed lumps and abscesses, mainly in areas where skin rubs together, like the armpits or groin. These can sometimes burst and form tunnels under the skin, which can be very uncomfortable.
The main goal of this research is to see if brensocatib works better than a placebo, which is a dummy medicine that looks the same but contains no active ingredients. Giving some participants the active medicine and some the placebo helps doctors understand if any changes or improvements are truly due to brensocatib or if they might happen naturally. We also want to make sure the medicine is safe to use and doesn't cause too many side effects.
Finding new ways to treat HS is really important because it can be a challenging condition to live with. This study could help us learn more about brensocatib and whether it could become a useful treatment option for people with moderate to severe HS in the future. Studies like this are how new treatments are discovered and approved to help patients.
النقاط الرئيسية
- This study is testing a new medicine for moderate to severe HS.
- It aims to see if brensocatib is safe and effective compared to a dummy pill (placebo).
- Participation involves regular clinic visits and close monitoring of your health.
- You might receive the active medicine or a placebo, and you won't know which one.
- The study could help find new treatments for HS. You can leave the study at any time.
من قد يكون مؤهلاً؟
To join this study, you need to be an adult between 18 and 80 years old, and you must have hidradenitis suppurativa (HS) that a skin doctor has confirmed. Your HS needs to have been present for at least six months and be considered moderate to severe, meaning you have at least six active painful lumps or pus-filled spots.
Your HS also needs to affect at least two different body areas, and at least one of these areas should be quite severe (what doctors call Hurley Stage II or III). You won't be able to join if you have many draining tunnels (20 or more) or if you've had surgery or laser treatment for your HS recently.
There are also some medical conditions and recent treatments that might prevent you from joining, such as certain blood conditions, active liver disease, or if you've recently taken certain strong antibiotics or other medicines for HS. This is to make sure the study is safe for everyone involved and that the results are clear.
هل يمكن أن تناسبك هذه الدراسة؟
أجب عن هذه الأسئلة السريعة لترى ما إذا كنت مؤهلاً. هذا دليل فقط - الفريق البحثي هو الذي يتخذ القرار النهائي.
- هل عمرك بين 18 و 80 سنة؟
- Has a skin doctor confirmed you have HS, and have you had it for at least 6 months?
- Do you currently have at least 6 active HS lumps or pus-filled spots?
- Does your HS affect at least two different body areas, with at least one being quite severe?
- Have you avoided surgery or laser treatment for HS in the last few weeks?
- Have you recently stopped or changed certain HS medications (like strong antibiotics or biologics) as per the study rules?
ماذا يتضمن المشاركة؟
If you decide to take part, you'll be assigned either to receive the study medicine (brensocatib) or a dummy medicine (placebo). You won't know which one you're getting, and neither will your study doctor. You'll need to visit the clinic regularly for check-ups, where the study team will monitor your HS, take blood samples, and ask about your health and any side effects. You might also need to keep a diary of your symptoms. The study will involve taking the medicine for a set period, followed by follow-up visits. The total duration of your involvement in the study will be explained in detail by the study team.
المخاطر والفوائد المحتملة
المواقع (72)
- USA001الرمز البريدي المؤكدفينيكس، الولايات المتحدة
- USA007الرمز البريدي المؤكدساكرامنتو، الولايات المتحدة
- USA026الرمز البريدي المؤكدكورال غيبلز، الولايات المتحدة
- USA027الرمز البريدي المؤكدهوليوود، الولايات المتحدة
- USA021الرمز البريدي المؤكدMargate, United States
- USA018الرمز البريدي المؤكدميامي، الولايات المتحدة
- USA025الرمز البريدي المؤكدأوكالا، الولايات المتحدة
- USA004الرمز البريدي المؤكدتامبا، الولايات المتحدة
- USA010الرمز البريدي المؤكدويستون، الولايات المتحدة
- USA028الرمز البريدي المؤكدأتلانتا، الولايات المتحدة
- USA011الرمز البريدي المؤكدSandy Springs, United States
- USA003الرمز البريدي المؤكدPlainfield, United States
أسئلة شائعة
ما هو التهاب الغدد العرقية القيحي (HS)؟
HS is a long-term skin condition that causes painful lumps, abscesses, and sometimes tunnels under the skin, usually in areas like the armpits, groin, or under the breasts.
ماذا يعني مصطلح 'بلاسيبو'؟
A placebo is a dummy medicine that looks like the real study drug but contains no active ingredients. It helps researchers see if the real medicine has a genuine effect.
هل سأعرف إذا كنت أحصل على الدواء الحقيقي أم الدواء الوهمي؟
No, during the study, neither you nor the doctors will know whether you are receiving brensocatib or the placebo. This is to keep the study fair and unbiased.
هل يمكنني مغادرة الدراسة في أي وقت؟
Yes, taking part is voluntary, and you can withdraw from the study at any time, for any reason, without affecting your regular medical care.
ما هو الهدف من هذه الدراسة؟
The main purpose is to see if brensocatib is safe and effective in treating moderate to severe HS compared to a placebo.
كيفية معرفة المزيد
تحدث دائمًا إلى طبيبك العام أو الأخصائي قبل اتخاذ قرار بالمشاركة في دراسة.
نقاش
مناقشة المجتمع
مدعوم من منتدانا في community.patient.info. يرجى التحلي بالاحترام — هذه ليست نصيحة طبية.